Integra LifeSciences IART Current portion of Term Loan
Current portion of Term Loan at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:SecuredDebtCurrent.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's current portion of term loan.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Integra LifeSciences's current portion of term loan?
- Integra LifeSciences (IART) reported current portion of term loan of $38.75M in Q1 2026.
- How has Integra LifeSciences's current portion of term loan changed year-over-year?
- Integra LifeSciences's current portion of term loan decreased by 0.0% year-over-year, from $38.75M to $38.75M.
- What is the long-term trend for Integra LifeSciences's current portion of term loan?
- Over 5 years (2020 to 2025), Integra LifeSciences's current portion of term loan has grown at a 2.8% compound annual growth rate (CAGR), from $33.75M to $38.75M.
- What does current portion of term loan mean?
- This represents the portion of long-term debt obligations that is due for repayment within the next twelve months. It serves as a critical indicator of a company's immediate liquidity requirements and its ability to meet short-term debt service obligations using current assets. Monitoring this figure helps investors assess the near-term refinancing risk and cash flow pressure on the business.